Skip to main content
Log in

Idelalisib recommended by NICE for CLL

  • Media release
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • NICE. NICE says yes to new class of drug for adults with leukaemia. Media Release : 24 Sep 2015. Available from: URL: http://www.nice.org.uk

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Idelalisib recommended by NICE for CLL. PharmacoEcon Outcomes News 738, 30 (2015). https://doi.org/10.1007/s40274-015-2512-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-015-2512-0

Navigation